This project aims to collect COVID-19 ICU patient samples to study the causes of death and disease progression. One of the lines of investigation is the formation of dangerous antibodies that induce blood clot formation. Read more
Our research focuses on the discovery and application of new science that aims to address the unmet medical needs of patients who currently suffer with incurable blood disorders. Our ongoing projects are focused on examining the changes in blood cell components which increase the likelihood of developing blood clots.
Details on our current research projects, including each project's current recruitment status, are provided below. If you are interested in participating in any of our projects, please visit participate in a research project.
Perth Blood Institute are partnering with Gamma Diagnostics Inc. to study the role that Gamma Prime Fibrinogen plays in various inflammatory disease states. Read more
A strategy towards novel biomarker discovery and personalised medicine. Read more
This project aims to restore Factor VIII protein functions by correcting the mutations with exon skipping as a novel therapeutic. Read more
This project aims to develop a method for screening patient samples for specific populations of anti-ADAMTS13 autoantibodies and determining their role in thrombotic disorders, including Thrombotic Thrombocytopenic Purpura onset and stroke. Read more
This study aims to utilise this knowledge to map oestrogen/hormone-responsive microRNAs, and decipher the role(s) of microRNAs in the regulation of haemostasis and thrombotic disorders. Read more